Eqz and OvF, thank you so much for all of the excellent research. I have been really time poor lately but, have some old but relevant snippets:
Dr. T Boreham's Crucible 22 July 2017: Proteomics is developing diagnostic tests for common disorders. It’s also researching biologics (protein based compounds) as generic drugs to replace versions going off patent. Biologics account for 20 percent of the drug market and at last count turned over close to $US50 billion a year. Proteins are present in every bodily cell, but not consistently so. Proteomics is the art of mapping the structure and function of proteins that, unlike genes, differ from cell to cell. Proteomics currently earns its revenue from analytic services to support clinical trials.
PrOMARKER D Asx: Nov. 2018
Market Cap.at $29m should be 10 times that, IMHO.
PIQ Price at posting:
36.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)